SCHEMBL6596647

SCHEMBL6596647

O=Cc1ccc(OC2CCN(C(=O)OCc3ccccc3)CC2)cc1

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.58
NPC1 O15118 2/20 0.58
RAB9A P51151 2/20 0.58
CYP2C19 P33261 1/20 0.56
GPR119 Q8TDV5 4/20 0.53
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
GRIN2B Q13224 7/20 0.48
HTT P42858 1/20 0.48
CYP2D6 P10635 4/20 0.47
CYP2C9 P11712 4/20 0.47
LNPEP Q9UIQ6 1/20 0.47
PDE4B Q07343 1/20 0.46
F13A1 P00488 1/20 0.46
TGM2 P21980 1/20 0.46
TGM1 P22735 1/20 0.46
CYP3A4 P08684 3/20 0.45
LMNA P02545 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13198831 0.87 SMN1; SMN2 (0.63) SMN1; SMN2NPC1RAB9ACYP2C19GPR119
SCHEMBL1648387 0.86 SMN1; SMN2 (0.61) SMN1; SMN2NPC1RAB9ACYP2C19GPR119
SCHEMBL1649138 0.86 SMN1; SMN2 (0.61) SMN1; SMN2NPC1RAB9ACYP2C19GPR119
SCHEMBL30120062 0.85 SMN1; SMN2 (0.60) SMN1; SMN2NPC1RAB9ACYP2C19GPR119
SCHEMBL4717723 0.84 SMN1; SMN2 (0.62) SMN1; SMN2NPC1RAB9ACYP2C19GPR119
SCHEMBL6593704 0.84 SMN1; SMN2 (0.56) SMN1; SMN2NPC1RAB9ACYP2C19GPR119
SCHEMBL8527326 0.84 HRH3 (0.52) SMN1; SMN2NPC1RAB9AGPR119LMNA
SCHEMBL23142005 0.84 SMN1; SMN2 (0.58) SMN1; SMN2NPC1RAB9ACYP2C19GPR119
SCHEMBL6599783 0.83 GAA (0.57) SMN1; SMN2NPC1RAB9AGPR119MEN1
SCHEMBL6597308 0.82 GPR119 (0.76) GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3819305-A1 AMIDE COMPOUND HAVING BET PROTEOLYSIS-INDUCING ACTION AND MEDICINAL APPLICATION THEREOF Mitsubishi Tanabe Pharma Corporation (JP) 2021-05-12 EP disclosed
EP-0981526-B1 NOVEL ANTIDIABETIC COMPOUNDS HAVING HYPOLIPIDAEMIC, ANTIHYPERTENSIVE PROPERTIES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM REDDYS LAB LTD DR (IN) 2004-02-25 EP disclosed
EP-0981526-A1 NOVEL ANTIDIABETIC COMPOUNDS HAVING HYPOLIPIDAEMIC, ANTIHYPERTENSIVE PROPERTIES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM DR. REDDY'S RESEARCH FOUNDATION (IN) 2000-03-01 EP disclosed
WO-1997041119-A1 NOVEL ANTIDIABETIC COMPOUNDS HAVING HYPOLIPIDAEMIC, ANTIHYPERTENSIVE PROPERTIES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM DR. REDDY'S RESEARCH FOUNDATION (IN) 1997-11-06 WO disclosed